Results of the trial, which involved more than 32,000 volunteers, showed two doses of the vaccine administered four weeks apart had an efficacy of 79% at preventing symptoms of COVID-19.
Copyright 2021 NPR
© 2024
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations